Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.
Age range
6 Months – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Visual Functions
Timeframe: 0-3 years depending on duration of treatment
Visual Functions
Timeframe: 0-3 years depending on duration of treatment
Visual functions
Timeframe: 0-3 years depending on duration of treatment
Visual functions
Timeframe: 0-3 years depending on duration of treatment
Visual functions
Timeframe: 0-3 years depending on duration of treatment
Visual functions
Timeframe: 0-3 years depending on duration of treatment
Visual functions
Timeframe: 0-3 years depending on duration of treatment